COVID-19 Vaccine ‘Booster’ Or Simply A Third Dose? US FDA’s Marks Starts To Reframe The Issue

 
• By Kate Rawson
High stakes poker
The stakes are high for the FDA advisory committee meeting on a third dose of Pfizer/BioNTech's COVID-19 vaccine. • Source: Alamy

More from Vaccines

More from Pink Sheet